The trademark TAFLOTAN was filed by Santen Pharmaceutical Co., Ltd., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on May 25, 2008, and received one opposition filed on August 24, 2008 by ALCON, INC. on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute, (c) Earlier non registered TM & right to prohibit use of later TM under national law. the opponent was represented by TOMKINS & CO. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 24, 2008
The application was filed in Finnish, and Finnish was also language of all opposition proceedings (English was selected as the second language).
The renewal of the trademark was recorded by the office on October 10, 2017.
Change of name and address of the trademark registration was recorded on January 26, 2015. Appointment and Replacement of representative of the trademark registration was recorded on July 13, 2015. Change of name and professional address of the trademark registration was recorded on January 30, 2019. Change of name and professional address of the trademark registration was recorded on January 29, 2020. Change of name and address of the trademark registration was recorded on March 24, 2020.